8 Drug-induced diabetes

Bailliere's Clinical Endocrinology and Metabolism

Volumn 6, Issue 4, 1992, Pages 849-866

  Ferner, R E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOXAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIAZOXIDE; ISONIAZID; NALIDIXIC ACID; ORAL CONTRACEPTIVE AGENT; STREPTOZOCIN; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; VACOR;

BODY BUILDING; DIABETES MELLITUS; DRUG INDUCED DISEASE; DRUG MEGADOSE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; PREGNANCY DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; INSULIN ANTAGONISTS; ISLETS OF LANGERHANS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0026470292     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(05)80170-3     Document Type: Article

References (111)

1. On the mechanism of diazoxide-induced hyperglycemia
2. Glucose intolerance during diuretic therapy
3. Effect of verapamil on blood glucose and serum insulin in patients with hyper- and hypothyroidism
4. + channels precedes depolarization-induced increase in cytoplasmic free calcium concentration in pancreatic B-cells
5. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy
6. Metabolic effect of prazosin
7. Life-threatening complications of betamimetic therapy for preterm labor inhibition
8. Do antihypertensive drugs precipitate diabetes?
9. Beta-blockers or diuretics in hypertension? a six year follow-up of blood pressure and metabolic side effects
10. Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection
11. Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro
12. Sulfonylurea receptors, ion channels, and fruit flies
13. Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man
14. Acute isoniazid poisoning
15. Fatal overdose of theophylline simulating acute pancreatitis
16. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects
17. Glucocorticoid-induced insulin resistance—the importance of postbinding events in the regulation of insulin binding, action and degradation in freshly isolated and primary cultures of rat hepatocytes
18. Salbutamol-induced acidosis in pregnant diabetics
19. Insulin resistance and diminished glucose tolerance in power-lifters ingesting anabolic steroids
20. Hypertension, the potassium ion and impaired carbohydrate tolerance
21. The effects of terbutaline on acid—base, serum electrolytes and glucose homeostasis during the management of preterm labor
22. The effect of diphenylhydantoin on insulin response
23. Fatal metabolic acidosis, hyperglycemia, and coma after steroid therapy for Kearns-Sayre syndrome
24. Calcium antagonists and islet function
25. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion
26. Diabetes & arterial hypertension
27. Physiological doses of epinephrine in the human: chronotropic but not hyperglycemic or catecholaminotropic
28. Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man
29. Cellular mechanism of action of loop diuretics: implications for drug effectiveness and adverse effects
30. Glibenclamide
31. Pharmacokinetics and toxic effects of diltiazem in massive overdose
32. Pharmacokinetics and toxic effects of nifedipine in massive overdose
33. Diabetes mellitus associated with autonomic and peripheral neuropathy after Vacor rodenticide poisoning: a review
34. Impairment of insulin secretion in man by nifedipine
35. Clinical toxicity of furosemide in hospitalized patients
36. Alternate day corticosteroid causes alternate day hyperglycaemia
37. Bumetanide: a new loop diuretic
38. The effect of oral salbutamol on serum potassium and blood sugar
39. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium
40. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension—the Oslo study
41. Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats
42. Treatment of autonomic neuropathy with a somatostatin analogue
43. Adverse effects of antihypertensive drug therapy on glucose intolerance
44. Convulsion, hyperglycemia, and glycosuria from overdose of nalidixic acid
45. Nephrotic-range proteinuria and hyperglycemia associated with clonidine therapy
46. Blood anions and electrolytes during ritodrine infusion in preterm labor
47. A possible mechanism of action for diazoxide
48. HYPERTENSION AND DIABETES
49. Long-term treatment of acromegaly with the somatostatin analogue—SMS 210–995
50. Nonketotic hyperosmolar coma and frusemide therapy
51. E. coli L-asparaginase and insulin release in vitro
52. Serial morphologic changes in rabbit pancreatic islet cells after streptozotocin
53. Letale iatrogen induzierte Hyperglykämie nach akzidenteller Glibenclamid-Einnahme
54. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment
55. Benylin dependence, metabolic acidosis and hyperglycaemia
56. Management of acute severe verapamil intoxication
57. Effect of diphenylhydantoin on insulin secretion in man
58. Evidence for an association of high blood pressure and hyperinsulinemia in obese man
59. Hyperglucagonism induced by glucocorticoid treatment in man
60. The glucose tolerance test in hypertensive patients treated long term with thiazide diuretics
61. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension
62. Induction of defective insulin secretion and impaired glucose tolerance by clonidine—selective stimulation of metabolic alpha-adrenergic pathways
63. Clinical features of the diabetic syndrome appearing after steroid therapy
64. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma
65. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up
66. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
67. Aspirin causes tissue insensitivity to insulin in normal man
68. Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes
69. Diabetogenic effect of pentamidine—in vitro and in vivo studies in a patient with malignant insulinoma
70. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects
71. Theophylline poisoning—a review of 64 cases
72. Effect of glucocorticoids on plasma insulin
73. Hyperglycemia with relative hypoinsulinemia in diphenylhydantoin toxicity
74. Management of chlorpropamide-induced hypoglycemia with diazoxide
75. Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy
76. Changes in carbohydrate tolerance during long-term oral contraception
77. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone
78. Hypertension as a disease of carbohydrate and lipoprotein metabolism
79. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation
80. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells
81. Effects of loop diuretics on carbohydrate metabolism and electrolyte excretion
82. Slow-release verapamil and hyperglycemic metabolic acidosis
83. Posttransplant hyperglycemia—increased incidence in cyclosporine-treated renal allograft recipients
84. Mechanisms of epinephrine-induced glucose intolerance in normal humans—role of the splanchnic bed
85. Encainide-induced hyperglycemia
86. Pentamidine and pancreatitis
87. Diabetogenic action of benzothiadiazines—serum-insulin-like activity in diabetes worsened or precipitated by thiazide diuretics
88. Fetal death associated with severe ritodrine induced ketoacidosis
89. Theophylline toxicity: clinical features of 116 consecutive cases
90. Pentamidine-induced pancreatic beta-cell dysfunction
91. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives
92. A review of carbohydrate metabolism and the oral contraceptive
93. Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome
94. Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone level in patients with cancer pain
95. Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive
96. Rifampicin-induced early phase hyperglycemia in humans
97. Non-ketotic diabetic precoma associated with high-dose frusemide therapy
98. Diabetogenic Action of Frusemide
99. Antihypertensive and biochemical effects of chlorthalidone
100. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis
101. Reversal of diazoxide effects by tolbutamide
102. Corticosteroid toxicity in neuro-oncology patients
103. New drugs for the treatment of hypertension
104. Oral contraceptives and diabetes mellitus
105. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus
106. Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism
107. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism
108. Effects of cyclosporine on glucose tolerance in the rat
109. Glucagon in acute ureteral colic
110. Pentamidine-associated fatal acute pancreatitis